Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing Technology;
June 13, 2006
CARLSBAD, Calif. & HAYWARD, Calif. & CAMBRIDGE, United Kingdom--Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Solexa, Inc. (Nasdaq:SLXA), a provider of next-generation genetic analysis systems, announced a collaboration through which Invitrogen will supply many of the reagents for Solexa's sequencing, gene expression, and small RNA [...]
Strategene and Takara Settle PCR Suits
June 12, 2006
Shiga, Japan: La Jolla, CA-Takara Bio and Stratagene have settled their patent disputes regarding enzyme blends used in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing [...]
Eksigent and Phenomenex Establish HPLC Marketing and Technology Alliance
June 12, 2006
Dublin, California, - Eksigent, a leading provider of capillary HPLC systems and Phenomenex, Inc., one of the world's largest manufacturers of HPLC columns, announce a strategic marketing and technology collaboration to develop columns optimized for capillary HPLC systems. Under the agreement, Phenomenex will offer a line of capillary HPLC columns that are tested and optimized [...]
June 6, 2006
DANVERS, Mass.---Cell Signaling Technology, Inc. (CST), announced that it has entered into a new partnership agreement with Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics. Under the new agreement, CST will develop antibodies for kinase activation and protein phosphorylation assays that will be [...]
Pharmaceutical equipment provider and optical sensing specialist join forces to develop TDLAS
June 5, 2006
BOC Edwards Pharmaceutical Systems and Physical Sciences Inc. (PSI) have signed a joint agreement to develop tunable diode laser absorption spectroscopy (TDLAS)-based technologies for pharmaceutical processing equipment. The two companies, who have already successfully completed a pilot project with a global pharmaceutical company in the US, are incorporating TDLAS into freeze-drying equipment. The result is [...]
June 5, 2006
BOSTON---PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, announced the acquisition of United Kingdom-based Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and managed maintenance company serving the pharmaceutical, biotechnology and healthcare markets. C&A, which generated revenues of approximately $7.5 million in 2005, will become an integral part [...]
CAI Latest Acquisition, Liston Scientific
June 2, 2006
California Analytical Instruments (CAI), located in Orange, CA. announced its acquisition of Liston Scientific, Irvine, CA. Liston`s support and manufacturing personnel and all manufacturing equipment and inventory will be moving to the CAI facility during the month of May. Minimal interruption in service and support levels of Liston Scientific Customers is expected during this period.
PALL Aims for $40 Million in Annualized Savings
June 1, 2006
East Hills, NY —Pall, a manufacturer of filtration, separation and purification products, announced that it has undertaken a cost reduction and facilities rationalization program that is expected to result in more than $40 million in annualized savings by the end of fiscal 2008. Pall will reduce its manufacturing footprint by 20%, or up to 12 [...]
Stratagene and Takara Settle PCR Suits
May 31, 2006
Shiga, Japan,: La Jolla, CA-Takara Bioand Stratagene have settled their patent disputes regarding enzyme blendsused in PCR technology. Financial details were unavailable. “We believe that there are a number of competitors selling products that are covered under our patent portfolio. It is our intention to make limited licenses available and recognize resulting licensing revenue,” stated [...]
May 31, 2006
PALO ALTO, Calif. & PARIS--Agilent Technologies Inc. (NYSE:A) and ExonHit Therapeutics (Euronext:ALEHT) announced that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products. These SpliceArrays include GPCR, Ion Channel, nuclear receptors and apoptosis pathways. SpliceArrays are a new generation of [...]
